EyeBiotech raised €61M in a Series A round in Nov 2023. The company is based in London, UK. Investors in the round: Bain Capital Life Sciences, Jeito Capital, MRL Ventures Fund and 4 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
